UNSPSC 51201821: Tiprotimod

This classification denotes an immunostimulant with the molecular formula C10H13NO4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FZ7ZH245CO, chemically known as 5-thiazoleacetic acid, 2-((3-carboxypropyl)thio)-4-methyl- but generally known as tiprotimod, which bears US NIH Compound Identifier 65890. European Medicines Agency schedules Tiprotimod in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11110MIG.

UNSPSC 51201821 Tiprotimod, a Commodity code, does not accurately reflect the vaccine procurement activity appearing under it in recent state and local opportunities. The single recent posting — a sole source notice from the Mississippi State Department of Health for Yellow Fever Vaccine from Sanofi Pasteur, Inc. — is epidemiologically and pharmacologically unrelated to Tiprotimod, which is an immune-response modifier used in other therapeutic contexts. The mismatch suggests either a data-entry error in the state procurement system or a misapplication of the UNSPSC code to this particular vaccine solicitation. State and local procurement records under this code show minimal relevant activity, and the nominal scope of the code itself does not align with the vaccine categories state and local health departments typically solicit.

The Mississippi State Department of Health posted the sole source notice on July 13, 2026, with objections due August 3, 2026 at 10:00 a.m. CST. The notice is procedural — it announces intent to procure the vaccine exclusively from Sanofi Pasteur and invites objections demonstrating alternative sources exist. No quantity, contract term, estimated value, or pricing is specified. Cynthia Brasher at the Mississippi State Department of Health Purchasing Department (Cynthia.brasher@msdh.ms.gov) is the point of contact. Given the code's apparent misapplication and the lack of other recent postings, this UNSPSC category does not represent active or recurring state and local procurement opportunity at this time.